Inactive Instrument

DATATRAK International, Inc. Stock Other OTC

Equities

DTRK

US2381342094

IT Services & Consulting

Dynamic Chart
Earnings Flash (DTRK) DATATRAK INTERNATIONAL Reports Q3 Revenue $1.5M MT
DATATRAK International, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021 CI
Datatrak International, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021 CI
Datatrak International, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2021 CI
Datatrak International, Inc. Launches ePRO, eCOA and eConsent Solution to Support the Advancement of Decentralized Trials Globally CI
Datatrak International, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2020 CI
Datatrak International, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2020 CI
Datatrak International, Inc. and RadMD Partner to Provide End to End Medical Imaging Solution CI
Datatrak International, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2020 CI
Datatrak International, Inc. Partners with Renibus Therapeutics, Inc. for Upcoming COVID-19 Clinical Trial CI
Datatrak International, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2020 CI
Datatrak International, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2019 CI
Datatrak International, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2019 CI
Datatrak International, Inc. Expands its Presence in the Asia-Pacific Region CI
Datatrak International, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2019 CI
More news
Managers TitleAgeSince
Chief Executive Officer 42 16-01-07
Members of the board TitleAgeSince
Director/Board Member 42 16-08-04
Chief Executive Officer 42 16-01-07
Director/Board Member 38 16-11-30
More insiders
Datatrak International, Inc. is a technology and services company. The Company is engaged in delivering global eClinical solutions for the clinical trials industry. The Company is focused on providing subscription and professional services. Its enterprise platforms include Decentralized Trials (including, electronic consent (e-Consent), electronic patient reported outcomes (e-PRO) and electronic clinical outcomes assessment (e-COA), electronic data capture, clinical trial management system (CTMS) and imaging and endpoint adjudication, randomization, and business intelligence. The Company’s CTMS includes functions for site feasibility and the tracking of action items and milestones. Its imaging and endpoint adjudication is a streamline the approach for managing imaging components while reducing manual workload and errors. Its business intelligence offers solution to create, monitor, and analyze user research and providing insights that allow to optimize processes from all aspects.
More about the company